loading
전일 마감가:
$1.21
열려 있는:
$1.24
하루 거래량:
64,763
Relative Volume:
0.35
시가총액:
$3.16M
수익:
-
순이익/손실:
$-15.08M
주가수익비율:
-0.1916
EPS:
-6.42
순현금흐름:
$-11.56M
1주 성능:
-1.60%
1개월 성능:
+4.24%
6개월 성능:
-77.12%
1년 성능:
-85.94%
1일 변동 폭
Value
$1.20
$1.2498
1주일 범위
Value
$1.19
$1.32
52주 변동 폭
Value
$1.01
$11.55

엔버릭 바이오 Stock (ENVB) Company Profile

Name
명칭
Enveric Biosciences Inc
Name
전화
239-302-1707
Name
주소
4851 TAMIAMI TRAIL N, SUITE 200, NAPLES
Name
직원
6
Name
트위터
Name
다음 수익 날짜
2024-11-11
Name
최신 SEC 제출 서류
Name
ENVB's Discussions on Twitter

ENVB을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ENVB
Enveric Biosciences Inc
1.24 3.16M 0 -15.08M -11.56M -6.42
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
451.91 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
537.25 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
321.13 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
547.08 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
243.26 28.51B 3.81B -644.79M -669.77M -6.24

엔버릭 바이오 주식(ENVB)의 최신 뉴스

pulisher
Jun 16, 2025

Enveric Biosciences Announces Participation in 2025 BIO International Convention | ENVB Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Enveric Biosciences Announces Participation in 2025 BIO International Convention - Business Wire

Jun 16, 2025
pulisher
Jun 10, 2025

Enveric Biosciences Receives Notice Of Allowance For New Class Of Low-Hallucinogenic Neuroplastogens Targeting Psychiatric Disorders - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

Enveric Biosciences Receives Notice of Allowance for New Class o - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Enveric Biosciences (ENVB) Gains Patent Approval for Innovative Compounds | ENVB Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Enveric Biosciences Receives Notice of Allowance for New Class of Low-Hallucinogenic Neuroplastogens Targeting Psychiatric Disorders | ENVB Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Enveric Biosciences Receives Notice of Allowance for New Class of Low-Hallucinogenic Neuroplastogens Targeting Psychiatric Disorders - Yahoo Finance

Jun 10, 2025
pulisher
Jun 04, 2025

Enveric Receives U.S. Patent for Sleep, CNS Therapeutics - Insider Monkey

Jun 04, 2025
pulisher
Jun 03, 2025

Enveric’s Patent Win Targets New Frontiers in Sleep Medicine - microdose.buzz

Jun 03, 2025
pulisher
Jun 03, 2025

Enveric Biosciences Holds 2025 Annual Stockholders Meeting - TipRanks

Jun 03, 2025
pulisher
Jun 03, 2025

Enveric Biosciences (ENVB) Secures Patent for Novel CNS Therapeu - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Enveric Biosciences Receives New US Patent on Molecules for Central Nervous System, Sleep Therapeutics - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Enveric Biosciences secures patent for sleep disorder molecules By Investing.com - Investing.com Nigeria

Jun 03, 2025
pulisher
Jun 03, 2025

Enveric Biosciences (ENVB) Secures Patent for Novel CNS Therapeutic Compounds | ENVB Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Enveric Biosciences Announces Issuance of U.S. Patent Covering a - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Enveric Biosciences Announces Issuance of U.S. Patent Covering a Novel Family of Molecules Including Melatonin Receptor-Targeting Compounds | ENVB Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Enveric Biosciences Announces Issuance of U.S. Patent Covering a Novel Family of Molecules Including Melatonin Receptor-Targeting Compounds - Yahoo Finance

Jun 03, 2025
pulisher
May 29, 2025

Enveric Biosciences announces results from EB-003 trial - Yahoo Finance

May 29, 2025
pulisher
May 29, 2025

Enveric’s EB-003 shows statistically significant improvements in model of severe chronic depression - BioWorld MedTech

May 29, 2025
pulisher
May 28, 2025

Enveric Biosciences Reports Positive Preclinical Results For Lead Drug Candidate EB-003 - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

Enveric Biosciences reports breakthrough in depression model By Investing.com - Investing.com India

May 28, 2025
pulisher
May 28, 2025

Enveric Biosciences (ENVB) Reports Promising Preclinical Results - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Enveric Biosciences reports breakthrough in depression model - Investing.com Australia

May 28, 2025
pulisher
May 28, 2025

Enveric Biosciences (ENVB) Reports Promising Preclinical Results for EB-003 | ENVB Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Enveric Biosciences Reports Positive Preclinical Results for Lead Drug Candidate EB-003 | ENVB Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Enveric Biosciences Reports Positive Preclinical Results for Lead Drug Candidate EB-003 - Business Wire

May 28, 2025
pulisher
May 28, 2025

Enveric Biosciences (NASDAQ:ENVB) Stock Price Down 0.8% – Here’s Why - Defense World

May 28, 2025
pulisher
May 20, 2025

Enveric Biosciences Identifies Neuroplastogen Candidates with Potential to Address Neurodegenerative Disease - marketscreener.com

May 20, 2025
pulisher
May 20, 2025

Enveric Biosciences Stakes Its Claim in Neurodegeneration Market - microdose.buzz

May 20, 2025
pulisher
May 20, 2025

Enveric Biosciences files provisional patent for new molecules By Investing.com - Investing.com Canada

May 20, 2025
pulisher
May 20, 2025

Enveric Biosciences Identifies Neuroplastogen Candidates with Po - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Enveric Biosciences (ENVB) Explores New Path with Neurodegenerative Drug Patent | ENVB Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Enveric Biosciences files new provisional patent application - TipRanks

May 20, 2025
pulisher
May 14, 2025

Enveric Biosciences Reports First Quarter 2025 Financial and Corporate Results - BioSpace

May 14, 2025
pulisher
May 14, 2025

Enveric Biosciences Reports First Quarter 2025 Financial and Cor - GuruFocus

May 14, 2025
pulisher
May 11, 2025

Enveric Biosciences (ENVB) Projected to Post Earnings on Tuesday - Defense World

May 11, 2025
pulisher
Apr 30, 2025

Enveric Biosciences stock plummets after pricing $5M capital raise - MSN

Apr 30, 2025
pulisher
Apr 17, 2025

Enveric Biosciences (NASDAQ:ENVB) Trading Down 1% – Here’s Why - Defense World

Apr 17, 2025
pulisher
Apr 15, 2025

Enveric Biosciences appoints new accounting firm - Investing.com India

Apr 15, 2025
pulisher
Apr 14, 2025

Enveric Biosciences appoints new accounting firm By Investing.com - Investing.com South Africa

Apr 14, 2025
pulisher
Apr 05, 2025

ENVB Stock Touches 52-Week Low at $1.12 Amid Market Challenges - Investing.com Canada

Apr 05, 2025
pulisher
Apr 04, 2025

ENVB Stock Touches 52-Week Low at $1.12 Amid Market Challenges By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Apr 03, 2025

Psychedelic: Enveric, Filament Health report earnings results - TipRanks

Apr 03, 2025
pulisher
Apr 01, 2025

Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2024 - BioSpace

Apr 01, 2025
pulisher
Mar 31, 2025

Enveric posts $9.5M loss for 2024, but revenue could be on horizon with licensing deals - Green Market Report

Mar 31, 2025
pulisher
Mar 31, 2025

Enveric Lands Massive $184M Biotech Licensing Deals as EB-003 Shows Promise - Stock Titan

Mar 31, 2025
pulisher
Mar 28, 2025

Enveric Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 28, 2025
pulisher
Mar 28, 2025

Enveric Biosciences, Inc. SEC 10-K Report - TradingView

Mar 28, 2025
pulisher
Mar 28, 2025

Enveric Biosciences Inc. (ENVB) reports earnings - qz.com

Mar 28, 2025
pulisher
Mar 21, 2025

Enveric Biosciences Inc expected to post a loss of 23 cents a shareEarnings Preview - TradingView

Mar 21, 2025
pulisher
Mar 18, 2025

Enveric Biosciences Announces 1-for-15 Reverse Stock Split - MSN

Mar 18, 2025

엔버릭 바이오 (ENVB) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.71
price up icon 0.31%
$35.79
price down icon 0.62%
$21.13
price down icon 0.56%
$97.56
price down icon 2.99%
$107.69
price up icon 1.16%
biotechnology ONC
$243.35
price up icon 0.69%
자본화:     |  볼륨(24시간):